Following the market opening Thursday, the Dow traded down 0.45% to 34,657.69 while the NASDAQ fell 0.66% to 15,061.97. The S&P also fell, dropping 0.62% to 4,453.04.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 41,539,100 cases with around 666,620 deaths. India confirmed a total of at least 33,347,320 cases and 443,920 deaths, while Brazil reported over 21,034,610 COVID-19 cases with 588,590 deaths. In total, there were at least 226,445,290 cases of COVID-19 worldwide with more than 4,661,150 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Financials shares slipped by just 0.2% on Thursday. Meanwhile, top gainers in the sector included Great Western Bancorp, Inc. (NYSE: GQB), up 12% and Metropolitan Bank Holding Corp. (NYSE: MCB) up 7%.
In trading on Thursday, materials shares tumbled 1.2%.
US retail sales increased 0.7% in August of 2021, following a revised 1.8% decline in July. Analysts were expecting for a 0.8% decline in retail trade.
Equities Trading UP
IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares shot up 32% to $42.44 amid increased retail investor interest in the stock on social media.
Shares of Dutch Bros Inc. (NYSE: BROS) got a boost, shooting 24% to $45.59. Dutch Bros shares surged around 60% on Wednesday in its public debut.
TMC the metals company Inc. (NASDAQ: TMC) shares were also up, gaining 24% to $12.35 amid increased retail investor interest in the stock on social media.
Equities Trading DOWN
Silverback Therapeutics, Inc. (NASDAQ: SBTX) shares tumbled 27% to $11.82. The company presented interim clinical results from a Phase 1/1b clinical study of SBT6050 as a monotherapy and in combination with Merck & Co's Keytruda in patients with advanced or metastatic HER2-expressing or amplified solid tumors.
Shares of Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) were down 24% to $11.87 after the company announced topline results of its Phase 2b COMET-1 study evaluating AR-15512 (TRPM8 Agonist) ophthalmic solution for dry eye disease. The company said that the study failed to achieve statistical significance at pre-determined primary endpoints at Day 28.
MacroGenics, Inc. (NASDAQ: MGNX) was down, falling 19% to $22.39 as the company disclosed results from Cohort A Part 1 of the Phase 2/3 MAHOGANY clinical trial of margetuximab.
In commodity news, oil traded down 0.3% to $72.41, while gold traded down 1% to $1,776.10.
Silver traded down 1.5% Thursday to $23.445 while copper fell 2% to $4.3180.
European shares were higher today. The eurozone’s STOXX 600 gained 0.7%, the Spanish Ibex Index rose 0.9% and the German DAX 30 gained 0.6%. Meanwhile, the London’s FTSE 100 rose 0.4%, French CAC 40 climbed 1.1% and Italy’s FTSE MIB jumped 1.1%.
The Eurozone trade surplus shrank to EUR 20.7 billion in July from EUR 26.8 billion in the year-ago period, while passenger car registrations in the European Union dropped 19.1% year-over-year to 623 thousand units in August. Italy’s trade surplus narrowed to EUR 8.762 billion in July from EUR 9.689 billion in the year-ago month.
US initial jobless claims increased to 332 thousand in the week ending September 11 versus a reading of 312 thousand in the previous week.
The Philadelphia Fed manufacturing index climbed to 30.7 in September from 19.4 in August.
Retail sales increased 0.7% in August of 2021, following a revised 1.8% decline in July.
US business inventories rose 0.5% for July.
The Energy Information Administration’s weekly report on natural gas stocks in underground storage is scheduled for release at 10:30 a.m. ET.
The Treasury is set to auction 4-and 8-week bills at 11:30 a.m. ET.
The Treasury International Capital report for July will be released at 4:00 p.m. ET.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.